Robust estimates of disease severity are still lacking, and the proportionate risk of severe maternal morbidity and mortality related to COVID-19 cannot be determined without analyzing large-scale pop
Research gap analysis derived from 3 medicine papers in our local library.
The gap
Robust estimates of disease severity are still lacking, and the proportionate risk of severe maternal morbidity and mortality related to COVID-19 cannot be determined without analyzing large-scale population-based data from several countrie
Consensus across the literature
Clustered from 3 gap mentions across 3 papers via embedding cosine ≥ 0.62.
Research trend
Established — well-defined area with open sub-problems.
Supporting evidence — 3 representative gaps
- Severe maternal morbidity and mortality associated with COVID‐19: The risk should not be downplayed (2020) · doi
Robust estimates of disease severity are still lacking, and the proportionate risk of severe maternal morbidity and mortality related to COVID-19 cannot be determined without analyzing large-scale population-based data from several countries adjusting for several confounding factors and outcome modifiers.
Keywords: several robust estimates disease severity still lacking proportionate risk severe maternal morbidity mortality related covid - COVID 19 management in newborn babies in the light of recent data: Breastfeeding, rooming-in and clinical symptoms (2020) · doi
Although there is a limited number of published data on babies of mothers who had COVID-19 infection in the last period of pregnancy and babies who had infection in the neonatal period, the effects of the virus on the fetus in the early period of pregnancy and the long-term problems of newborn babies remain unknown.
Keywords: babies period infection pregnancy there limited number published mothers covid last neonatal effects virus fetus - COVID-19 Pandemic and Birth Experience. The Monopoly of Caesarean Sections. A Critical Realist Review (2021) · doi
Despite the increasing number of published studies on COVID-19 in pregnancy, there are insufficient good-quality data to draw unbiased conclusions with regard to the severity of the disease or specific complications of COVID-19 with reference to the mode of delivery, vertical/peripartum transmission, and complications in neonates, born by infected pregnant women.
Keywords: covid complications despite increasing number published pregnancy there insufficient good quality draw unbiased conclusions regard
Explore this gap further
Search “Robust estimates of disease severity are still lacking, and the proportionate risk of severe maternal morbidity and mortality related to COVID-19 cannot be determined without analyzing large-scale pop” across open scholarly engines for the latest related literature.
Working on this gap? Publish with us.
Science AI Journal reviews manuscripts in under 15 minutes with 8 specialised AI reviewers calibrated on 23,000+ real peer reviews. Open access, CC BY 4.0.
Free tools for your next paper
Related gaps in Medicine
- Liability and legal frameworks for organizations using AI in clinical decision-making processes require development and clarification.Liability and legal frameworks for organizations using AI in clinical decision-making processes require development and clarification.
- Recent literature from 2025 to 2026 has firmly established AI as a core driver in the methodological evolution of precision oncology for HCC. By implementing VFMs to mitigate imaging domain shifts andRecent literature from 2025 to 2026 has firmly established AI as a core driver in the methodological evolution of precision oncology for HCC.…
- PURPOSE: The aim of this review was to critically appraise the literature on the use of antibiotics to treat peri-implantitis, with the ultimate goal of supporting evidence-based clinical recommendatiPURPOSE: The aim of this review was to critically appraise the literature on the use of antibiotics to treat peri-implantitis, with the ulti…
- External validation is required before the model can be applied in clinical settings.External validation is required before the model can be applied in clinical settings.